Medical Condition News

RSS

World Cancer Day highlights importance of detection, prevention

"Early diagnosis is the key to reducing the nearly eight million deaths caused by cancer across the globe annually, the United Nations World Health Organization (WHO) said" on Saturday to mark World Cancer Day, "stressing the importance of screening programs for healthy people to detect the disease promptly for easier treatment," the U.N. News Centre reports (2/3).

6 Feb 2012

Body's zinc control mechanisms may be key to aggressive breast cancer treatments

The body's control mechanisms for delivering zinc to cells could be key to improving treatment for some types of aggressive breast cancer.

6 Feb 2012

Comprehensive program to help reduce health risks of narcotics drugs on injured workers

Accident Fund Holdings, Inc. recently created a comprehensive narcotics program to help reduce the health risks of these drugs on injured workers and ultimately provide a mechanism for them to get back to work sooner.

6 Feb 2012

Environmental aspects rather than genes play a major role in MCI in non-demented elderly

Both subjective and objective cognitive impairment are highly common among non-demented elderly Swedes, with an overall prevalence of 39 percent and 25 percent respectively, according to a nationwide twin study by researchers at the Aging Research Center of Karolinska Institutet, Sweden.

6 Feb 2012

Emergent Financial Group raises $11.8M for Tenex Health

Emergent Financial Group, Inc. today announced the completion of a $11.8 million private placement transaction for Tenex Health Inc., a California-based medical technology company developing the FAST Procedure (Focused Aspiration of Scar Tissue) for the treatment of tendon injuries.

6 Feb 2012

Positive results from Chimerix CMX001 study for CMV in hematopoietic stem cell transplant recipients

Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV) disease in hematopoietic stem cell transplant (HCT) recipients.

6 Feb 2012

Orexigen reaches SPA agreement for Contrave outcomes trial with FDA

Orexigen Therapeutics, Inc. today announced that it has reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for the Contrave outcomes trial.

6 Feb 2012

TeDan Surgical launches Phantom Series MIS Anterior Hip Retractor System

TeDan Surgical Innovations, industry leader in surgical access instrumentation, announces the launch of the Phantom Series MIS Anterior Hip Retractor System. TeDan Surgical's revolutionary hip retractor utilizes a system of adjustable surgical arms with attachable retractors, enabling surgeons to perform the entire procedure without a fracture table or a surgical assistant.

6 Feb 2012

ABC2, Exosome collaborate to explore RNA biofluid-based diagnostic technology in brain cancer

Accelerate Brain Cancer Cure and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.

6 Feb 2012

Boston Scientific launches Expect 19 Flex Endoscopic Ultrasound Aspiration Needle

Boston Scientific Corporation announces the global launch of the Expect 19 Flex Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples under Endoscopic Ultrasound (EUS) guidance for cancer diagnosis in organs adjacent to the gastrointestinal tract.

6 Feb 2012

Sandoz sends Remodulin Paragraph IV Notice Letter to United Therapeutics

United Therapeutics Corporation today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. advising that Sandoz has submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration requesting approval to market a generic version of the 10 mg/mL strength of Remodulin (treprostinil) injection.

6 Feb 2012

Positive clinical results from randomized trial of InspireMD's MGuard in STEMI patients

InspireMD, Inc., a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, announced positive clinical results from an investigator-sponsored controlled randomized trial conducted in Chile.

6 Feb 2012

Russian neurosurgical institute acquires Leksell Gamma Knife Perfexion system

Russia's first Leksell Gamma Knife Perfexion system has found a home at the renowned N.N. Burdenko Neurosurgical Institute, just a five-minute car ride from Moscow's Red Square.

From Elekta 6 Feb 2012

Takeda launches EDARBYCLOR in the U.S. for treatment of hypertension

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., announced EDARBYCLOR (azilsartan medoxomil and chlorthalidone) is now available by prescription in U.S. pharmacies for the treatment of hypertension to lower blood pressure in adults.

6 Feb 2012

Pyromaker can more accurately identify complex genetic mutations

DNA sequencing to detect genetic mutations can aid in the diagnosis and selection of treatment for cancer. Current methods of testing DNA samples, Sanger sequencing and pyrosequencing, occasionally produce complex results that can be difficult or impossible to interpret. Scientists at the Johns Hopkins University School of Medicine have developed a free software program, Pyromaker, that can more accurately identify such complex genetic mutations.

6 Feb 2012

Clinuvel submits SCENESSE MAA to EMA for treatment of erythropoietic protoporphyria

Clinuvel Pharmaceuticals Limited today announced that it has submitted a marketing authorisation application (MAA) for its first-in-class drug SCENESSE (afamelanotide 16mg implant) to the European Medicines Agency.

6 Feb 2012

CD74 molecule plays a guiding role in immune responses against diseases

University of British Columbia researchers have discovered the molecular pathway that enables receptors inside immune cells to find, and flag, fragments of pathogens trying to invade a host.

6 Feb 2012

Scientists identify genetic variant that increases risk of ischemic stroke

A genetic variant that increases the risk of a common type of stroke has been identified by scientists in a study published online in Nature Genetics today. This is one of the few genetic variants to date to be associated with risk of stroke and the discovery opens up new possibilities for treatment.

6 Feb 2012

Two molecules hold promise as a biomarker for OA

Henry Ford Hospital researchers have identified for the first time two molecules that hold promise as a biomarker for measuring cartilage damage associated with osteoarthritis.

5 Feb 2012

New stent retriever procedure safe, effective for patients with stroke

A new way of opening blocked arteries in the brain using a removable stent system in people suffering strokes brought remarkably positive results in how those patients recovered from the strokes, according to a study presented this morning at the American Stroke Association's annual conference in New Orleans.

4 Feb 2012

Medical Condition News

World Cancer Day highlights importance of detection, prevention

Body's zinc control mechanisms may be key to aggressive breast cancer treatments

Comprehensive program to help reduce health risks of narcotics drugs on injured workers

Environmental aspects rather than genes play a major role in MCI in non-demented elderly

Emergent Financial Group raises $11.8M for Tenex Health

Positive results from Chimerix CMX001 study for CMV in hematopoietic stem cell transplant recipients

Orexigen reaches SPA agreement for Contrave outcomes trial with FDA

TeDan Surgical launches Phantom Series MIS Anterior Hip Retractor System

ABC2, Exosome collaborate to explore RNA biofluid-based diagnostic technology in brain cancer

Boston Scientific launches Expect 19 Flex Endoscopic Ultrasound Aspiration Needle

Sandoz sends Remodulin Paragraph IV Notice Letter to United Therapeutics

Positive clinical results from randomized trial of InspireMD's MGuard in STEMI patients

Russian neurosurgical institute acquires Leksell Gamma Knife Perfexion system

Takeda launches EDARBYCLOR in the U.S. for treatment of hypertension

Pyromaker can more accurately identify complex genetic mutations

Clinuvel submits SCENESSE MAA to EMA for treatment of erythropoietic protoporphyria

CD74 molecule plays a guiding role in immune responses against diseases

Scientists identify genetic variant that increases risk of ischemic stroke

Two molecules hold promise as a biomarker for OA

New stent retriever procedure safe, effective for patients with stroke

Making Complex Cell Culture Easy and Efficient with AI

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Microphysiological systems in drug discovery

Latest News